Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exact Sciences Cor
(NQ:
EXAS
)
50.38
-1.57 (-3.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Exact Sciences Cor
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
September 23, 2022
The World Health Organization (WHO) warned that it struggles to identify and
Via
Benzinga
7 Nasdaq Stocks to Buy on the Dip or You’ll Be Kicking Yourself Later
September 21, 2022
Investors should consider buying these Nasdaq stocks on the dip while they still can before the market reverses higher.
Via
InvestorPlace
No More Free COVID-19 At-Home Tests, Federal Government Says
August 29, 2022
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au
Via
Benzinga
Expert Ratings for Exact Sciences
August 03, 2022
Within the last quarter, Exact Sciences (NASDAQ:EXAS) has observed the following analyst ratings:
Via
Benzinga
Expert Ratings for Exact Sciences
June 03, 2022
Exact Sciences (NASDAQ:EXAS) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
Upgrades
Via
Benzinga
What 9 Analyst Ratings Have To Say About Exact Sciences
August 25, 2022
Exact Sciences (NASDAQ:EXAS) has observed the following analyst ratings within the last quarter:
Via
Benzinga
5 Top Stocks Cathie Wood Bought This Week
August 05, 2022
Cathie Wood continues to increase positions in some of her top stocks despite recession fears. She bought names like EXAS and PACB this week.
Via
InvestorPlace
Non-COVID Sales Boost Exact Sciences' Q1 Revenue; Revises FY22 Guidance
April 27, 2022
Via
Benzinga
Earnings Scheduled For April 26, 2022
April 26, 2022
Companies Reporting Before The Bell • First American Financial (NYSE:FAF) is estimated to report quarterly loss at $0.09 per share on revenue of $46.41 million.
Via
Benzinga
Analyst Ratings for Exact Sciences
April 19, 2022
Within the last quarter, Exact Sciences (NASDAQ:EXAS) has observed the following analyst ratings:
Via
Benzinga
Cathie Wood Sheds $5M In CRISPR Therapeutics, Scoops Up These Biotech Stocks Instead
August 05, 2022
Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG (NASDAQ: CRSP), valued at over $5.58 million, via its flagship fund.
Via
Benzinga
Exact Sciences: Q2 Earnings Insights
August 02, 2022
Exact Sciences (NASDAQ:EXAS) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Exact Sciences beat estimated...
Via
Benzinga
Small Cap Biotech Stocks Are Trending Well
July 18, 2022
Despite a little weakness last week, small cap biotechs are trending well for traders. For investors entering the trade on July 5 all of our. focus stocks are up except ChemoCentryx.
Via
Talk Markets
6 Cathie Wood Stocks to Buy on the Dip
July 14, 2022
As major holdings in her portfolios, these Cathie Wood stocks to buy on the dips are likely to significantly pop when the market recovers.
Via
InvestorPlace
5 Cathie Wood Stocks to Buy in June
June 09, 2022
These are the five best Cathie Wood stocks to buy in June. EXAS, IONS, KTOS, TRMB, and PATH can make excellent investments.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022
June 03, 2022
Via
Benzinga
Why Ark Innovation ETF Hit 52-Week Lows Today
May 09, 2022
ARK Innovation ETF (ARCA:ARKK) is making new 52-week lows on Monday, led by sharp declines in the top holdings of Ark's flagship fund.
Via
Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
May 06, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Exact Sciences's Return On Capital Employed Insights
April 28, 2022
According to data from Benzinga Pro, during Q1, Exact Sciences's (NASDAQ:EXAS) reported sales totaled $486.57 million. Despite a 17.98% increase in earnings, the company posted a loss of $180.94...
Via
Benzinga
SVB Leerink Maintains Outperform Rating for Exact Sciences: Here's What You Need To Know
April 27, 2022
SVB Leerink has decided to maintain its Outperform rating of Exact Sciences (NASDAQ:EXAS) and lower its price target from $130.00 to $95.00. Shares of Exact Sciences are trading up 7.86% over the last...
Via
Benzinga
Here's How Much You Would Have Made Owning Exact Sciences Stock In The Last 10 Years
April 27, 2022
Exact Sciences (NASDAQ:EXAS) has outperformed the market over the past 10 years by 7.98% on an annualized basis producing an average annual return of 19.54%. Currently, Exact Sciences has a market...
Via
Benzinga
Preview: Exact Sciences's Earnings
April 25, 2022
Exact Sciences (NASDAQ:EXAS) is set to give its latest quarterly earnings report on Tuesday, 2022-04-26. Here's what investors need to know before the announcement. Analysts estimate that Exact...
Via
Benzinga
Here's How Much $1000 Invested In Exact Sciences 20 Years Ago Would Be Worth Today
April 06, 2022
Exact Sciences (NASDAQ:EXAS) has outperformed the market over the past 20 years by 2.83% on an annualized basis producing an average annual return of 10.04%. Currently, Exact Sciences has a market...
Via
Benzinga
How do Biotechnology Funds and ETFs Perform Over Five Years?
March 21, 2022
Biotech investing can be difficult for short-term traders but can offer good returns over five years if balanced with other healthcare positions like the XLV.
Via
Talk Markets
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much
March 17, 2022
Exact Sciences (NASDAQ:EXAS) has outperformed the market over the past 5 years by 12.08% on an annualized basis. Buying $100 In EXAS: 5 years ago, an investor could have...
Via
Benzinga
Tesla, Coinbase, Exact Sciences And More: How Cathie Wood's Top 10 Bets Are Faring In 2022 So Far
March 14, 2022
Popular stockpicker Cathie Wood-led Ark Investment Management’s top ten key bets — spread across clean energy, innovation, tech, healthcare, and space...
Via
Benzinga
Where Exact Sciences Stands With Analysts
February 23, 2022
Over the past 3 months, 4 analysts have published their opinion on Exact Sciences (NASDAQ:EXAS) stock. These analysts are typically employed by large Wall Street banks and tasked...
Via
Benzinga
Exact Sciences Clocks 16% Jump In Q4 Non-COVID-19 Revenues
February 23, 2022
Exact Sciences Corp's (NASDAQ: EXAS) Q4 revenues increased 2% Y/Y to $473.8 million and beat the average Wall Street estimate of $449 million. Excluding COVID-...
Via
Benzinga
4 Big Ark Innovation Components Report Earnings This Week: Could It Spell More Danger For Cathie Wood?
February 23, 2022
The Ark Funds ETFs have been hit hard in 2022 with growth stocks among the laggards as investors turned to value stocks. Many stockholders have begun to question ...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.